Showing results (151-160 of 205) with videos related to

Sort By:
Pageof 21
Pharmacological Research Communications|November 1, 1985
Gastric pharmacological activities of tripotassium dicitrato bismuthate in rats and dogsG Soldani, M Del Tacca, C Bernardini, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1996
Azidothymidine in combination with 5-fluorouracil in human colorectal cell lines: in vitro synergistic cytotoxicity and DNA-induced strand-breaksM Andreuccetti, G Allegrini, A Antonuzzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Intravenous azidothymidine with fluorouracil and leucovorin: a phase I-II study in previously untreated metastatic colorectal cancer patientsA Falcone, R Danesi, F Dargenio, et al.
European Journal of Clinical Pharmacology|February 27, 2003
Severe 5-fluorouracil toxicity associated with a marked alteration of pharmacokinetics of 5-fluorouracil and its catabolite 5-fluoro-5,6-dihydrouracil: a case reportG Bocci, R Danesi, G Allegrini, et al.
Toxicology|November 15, 1992
Characterization of the toxicity of distamycin derivatives on cancer cell lines and rat heartC Agen, A M Sironi, R Danesi, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|December 1, 1986
Pirenzepine versus ranitidine in gastroprotection during antiblastic chemotherapy: a double-blind studyA Polloni, S Marchi, A Martire, et al.
The Journal of Antimicrobial Chemotherapy|February 7, 2008
Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycinM Lucchi, B Damle, A Fang, et al.
British Journal of Cancer|June 1, 2001
Inhibition of protein farnesylation enhances the chemotherapeutic efficacy of the novel geranylgeranyltransferase inhibitor BAL9611 in human colon cancer cellsA Di Paolo, R Danesi, S Caputo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Cardiotoxicity of epirubicin/paclitaxel-containing regimens: role of cardiac risk factorsA Gennari, B Salvadori, S Donati, et al.
Journal of Medicinal Chemistry|February 1, 1983
Conformational effects on the activity of drugs. 10. Synthesis, conformation, and pharmacological properties of 1-(2,5-dimethoxyphenyl)-2-aminoethanols and their morpholine analoguesE Epifani, A Lapucci, B Macchia, et al.
Pageof 21